Discover
PTCT
PTC Therapeutics, Inc.
73.31
1 x 73.23
1 x 73.33
bid
ask
-
1.31
1.76%
12:36 PM
timesize
| Ytd | -3.48% | |
| 1y | 69.32% |
72.83
day range
74.91
43.32
52 week range
90.87
| Open | 74.91 | Prev Close | 74.63 | Low | 72.83 | High | 74.91 | Mkt Cap | 6.12B |
| Vol | 283.83K | Avg Vol | 1.74M | EPS | -2.33 | P/E | -31.46 | Forward P/E | 29.32 |
| Beta | 0.56 | Short Ratio | 3.61 | Inst. Own | 119.01% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 77.27 | 200-d Avg | 73.23 | 1yr Est | 97.86 |
| Income Statement | |||
| Total Revenue | 360.52M | ||
| Revenues (USD) | 360.52M | ||
| Cost of Revenue | 19.92M | ||
| Gross Profit | 340.60M | ||
| Operating Expenses | 191.62M | ||
| Research and Development Expense | 99.15M | ||
| Selling, General and Administrative Expense | 80.63M | ||
| Operating Income | 148.98M | ||
| Interest Expense | 48.48M | ||
| Income Tax Expense | 14.05M | ||
| Net Income | 83.50M | ||
| Net Income Common Stock | 83.50M | ||
| Net Income Common Stock (USD) | 83.50M | ||
| Consolidated Income | 83.50M | ||
| Earnings per Basic Share | 1.01 | ||
| Earnings per Basic Share (USD) | 1.01 | ||
| Earnings per Diluted Share | 0.92 | ||
| Earning Before Interest & Taxes (EBIT) | 146.03M | ||
| Earning Before Interest & Taxes (USD) | 146.03M | ||
| Weighted Average Shares | 83.01M | ||
| Weighted Average Shares Diluted | 92.02M | ||
| Balance Sheet | |||
| Cash and Equivalents | 1.05B | ||
| Cash and Equivalents (USD) | 1.05B | ||
| Investments | 1.18B | ||
| Investments Current | 1.18B | ||
| Trade and Non-Trade Receivables | 239.04M | ||
| Current Assets | 2.62B | ||
| Property, Plant & Equipment Net | 126.27M | ||
| Total Assets | 3.25B | ||
| Debt Current | 73.42M | ||
| Total Debt | 696.47M | ||
| Current Liabilities | 771.07M | ||
| Debt Non-Current | 623.05M | ||
| Total Liabilities | 3.42B | ||
| Accumulated Retained Earnings (Deficit) | -2.88B | ||
| Accumulated Other Comprehensive Income | 6.02M | ||
| Shareholders Equity | -165.36M | ||
| Shareholders Equity (USD) | -165.36M | ||
| Assets Non-Current | 633.12M | ||
| Total Debt (USD) | 696.47M | ||
| Deferred Revenue | 1.19M | ||
| Goodwill and Intangible Assets | 485.27M | ||
| Inventory | 91.35M | ||
| Liabilities Non-Current | 2.64B | ||
| Trade and Non-Trade Payables | 382.25M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 17.67M | ||
| Net Cash Flow from Financing | 211.88M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 215.90M | ||
| Capital Expenditure | -2.19M | ||
| Net Cash Flow - Business Acquisitions and Disposals | -4.95M | ||
| Issuance (Purchase) of Equity Shares | 16.40M | ||
| Issuance (Repayment) of Debt Securities | 209.23M | ||
| Net Cash Flow from Investing | -122.56M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -115.41M | ||
| Net Cash Flow from Operations | 129.11M | ||
| Effect of Exchange Rate Changes on Cash | -2.54M | ||
| Share Based Compensation | 23.29M | ||